Trial Profile
Study on the safety and efficacy of recombinant hepatitis B immunogenic complex therapeutic vaccine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant-hepatitis B immune globulin complex (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Planned number of patients is 240 as reported by Chinese Clinical Trial Register.
- 21 May 2012 Actual end date (31 Dec 2006) added as reported by Chinese Clinical Trial Register.
- 21 May 2012 Actual initiation date (1 Sep 2005) added as reported by Chinese Clinical Trial Register.